SCHEMBL6744136

SCHEMBL6744136

COc1cc(C)cc(-c2nnn[nH]2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ROS1 P08922 1/20 0.37
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
CYP1A1 P04798 3/20 0.34
CYP1B1 Q16678 3/20 0.34
CYP2C9 P11712 2/20 0.33
GRK6 P43250 1/20 0.33
POLB P06746 1/20 0.33
TP53 P04637 1/20 0.33
ACHE P22303 1/20 0.32
KDM4E B2RXH2 1/20 0.32
POLQ O75417 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2E1 P05181 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C8 P10632 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6744130 0.85 POLB (0.33) CYP2C9POLB
SCHEMBL6741105 0.84 NOTUM (0.36) CYP2C9POLB
SCHEMBL31357013 0.77 CYP1A1 (0.46) CYP1A1CYP1B1CYP2C9CYP1A2CYP3A4
SCHEMBL703677 0.77 DCUN1D1 (0.54) MAPTGAACYP2C9GRK6KDM4E
SCHEMBL6741100 0.76
SCHEMBL730902 0.75 ALDH1A1 (0.34) ALDH1A1HSD17B10HPGDSMN1; SMN2MAPT
SCHEMBL672108 0.75 KDM4E (0.50) ALDH1A1HPGDSMN1; SMN2MAPTGAA
SCHEMBL18758173 0.74 XDH (0.50) ALDH1A1HPGDSMN1; SMN2MAPTGAA
SCHEMBL2952197 0.73 ALDH1A1 (0.53) ALDH1A1CYP1A1CYP1B1CYP2C9TP53
SCHEMBL20440761 0.72 NOTUM (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6610731-B2 Antiinflammatory BRISTOL-MYERS SQUIBB COMPANY 2003-08-26 US disclosed
US-6403632-B1 CYCLIC AMIDE DERIVATIVE BRISTOL MYERS SQUIBB PHARMA CO (US) 2002-06-11 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed
US-6057336-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-05-02 US disclosed